Ara
Toplam kayıt 1, listelenen: 1-1
The Incidence of Ototoxicity in Patients Using Iron Chelators
(Aves, 2017)
OBJECTIVE: In this study, we aimed to detect the incidences of ototoxicity in patients with hemoglobinopathies taking deferoxamine (DFO), deferiprone, and deferasirox using the National Cancer Institute (NCI) Common ...